期刊文献+

间充质干细胞构建组织工程瓣膜的生物力学性能研究 被引量:1

Biomechanical Properties of Tissue Engineered Heart Valve Using Mesenchymal Stem Cells as Seed Cells
下载PDF
导出
摘要 目的采用碱性成纤维细胞生长因子(basic fibroblast growth factor,bFGF)联合间充质干细胞(mesenchy-mal stemcells,MSCs)构建组织工程心脏瓣膜(tissue engineered heart valve,TEHV),并对其生物力学性能进行研究。方法分离培养大鼠MSCs,进行细胞鉴定后种植于去细胞瓣叶支架上。将瓣叶置于含5 ng/ml bFGF的培养液中,分别培养7 d和14 d作为实验组A和实验组B。实验组C除培养液中不添加bFGF外,其余同实验组B。对照组为大鼠肌成纤维细胞构建的TEHV。对各组TEHV进行形态学观察,生化检测和生物力学测试。结果MSCs表达CD29(94.82%)和CD44(93.59%)。各组TEHV具有相似的形态结构,DNA和羟脯氨酸含量、最大负荷、最大应力、最大应变和弹性模量的差异无统计学意义(P>0.05)。结论采用MSCs和肌成纤维细胞构建的TEHV具有相同的生物力学性能,而采用bFGF联合MSCs体外构建TEHV能在更短的时间内获得相同的生物力学性能。 Objective Tissue engineered heart valve(TEHV) was constructed using bFGF and mesenchymal stem cells (MSCs). And its biomechanical properties were investigated. Methods MSCs were isolated and cultured. After cell identification,MSCs were seeded onto decellularized aortic valve leaflet scaffold to constuct TEHV in each group. TEHV were cutlured with DMEM containing 5 ng/ml bFGF in vitro for 7 d in group A or 14 d in group B. In group C,TEHV was cutlured with DMEM only for 14 d. In control group,TEHV were constructed using myofibroblasts as seed cells. TEHV in each group was examined morphologically,biochemically and biomeehanically. Results MSCs expressed CD29(94.82%) and CIM4(93. 59%). TEHV in each group showed simliar morphologcical structure. And the differences of DNA and hydroxyproline contents, Max-load, Maxstress,elastic modulus and Max-strain between groups had no statistically significant difference(P〉0.05). Conclusion The biomechanical properties of TEHV using MSCs as seed cells were equal to TEHV using myofibroblast as seed cells. However, construction of TEHV using bFGF and MSCs can shorten the time of construction in vitro with the same biomechanical properties.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2009年第2期220-223,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.30571839和30600608) 国家高技术研究发展计划资助项目(No.2009AA03Z420)
关键词 碱性成纤维细胞生长因子 间充质干细胞 组织工程瓣膜 生物力学 basic fihroblast growth factor mesenchymal stem cells tissue engineered heart valve biomechanical properties
  • 相关文献

参考文献11

  • 1KNIGHT R L,WILCOX H E,KOROSSIS S A,et al. The use of acellular matrices for the tissue engineering of cardiac valves[J]. Proc Inst Mech Eng,2008,222(1):129-143.
  • 2董念国,叶晓峰,史嘉玮,宋强,孙宗全.组织工程瓣膜天然支架去细胞方法的比较[J].中华实验外科杂志,2005,22(3):377-377. 被引量:46
  • 3史嘉玮,董念国,孙宗全,仇玉明.RGD肽联合转化生长因子-β_1对组织工程瓣膜构建的影响[J].中华医学杂志,2006,86(29):2074-2077. 被引量:11
  • 4韩啸,蒋雄刚,徐鹏,张凯伦,杨华静.聚乙二醇和胰蛋白酶用于猪动脉管道去细胞效果比较[J].华中科技大学学报(医学版),2007,36(4):551-553. 被引量:4
  • 5SUTHERLAND F W H,PERRY T E,YING Y,et al. From stem cells to viable autologous semilunar heart valve[J]. Circulation,2005,111(21) : 2783-2791.
  • 6KADNER A, HOERSTRUP S P, ZUND G, et al. A new source for cardiovascular tissue engineering: human bone marrow stromal cells[J]. Eur J Cardiothorac Surg, 2002,21 (6) : 1055-1060.
  • 7HOERSTRUP S P, KADNER A, MELNITCHOUK S, et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells[J]. Circulation, 2002, 106 ( 12 Suppl 1): 143-150.
  • 8孙晓宁,赵强,徐德民,陈安清,翟万银,常江.骨髓间充质干细胞和猪去细胞瓣膜支架构建组织工程瓣膜[J].复旦学报(医学版),2007,34(2):183-186. 被引量:7
  • 9VINCENTELLI A,WAUTOT F,JUTHIER F,et al. In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates ? [J]. J Thorac Cardiovasc Surg, 2007, 134 (2) : 424-432.
  • 10SCHOEN J F. New frontiers in the pathology and therapy of heart valve disease: 2006 Society for Cardiovascular Pathology, Distinguished Achievement Award Lecture, United States- Canadian Academy of Pathology, Atlanta, GA, February 12, 2006[J]. Cardiovase Pathol,2006,15(5) :271-279.

二级参考文献29

共引文献51

同被引文献16

  • 1Sulkowski S,Nowak H F,Szynaka B.Alveolar epithelial cells in experimental lung emphysema,ultrastructural analysis of cells in situ in TEM[J].Exp Toxicol Pathol,1994,45(8):513-518.
  • 2Aoshiba K,Yokohori N,Nagai A.Alveolar wall apoptosis induces lung destruction and emphysematous changes[J].Am J Respir Cell Mol Biol,2003,28(5):555-562.
  • 3Theise N D,Henegariu O,Grove J,et al.Radiation pneumonitis in mice:a severe injury model for pneumocyte engraftment from bone marrow[J].Exp Hematol,2002,30(11):1333-1338.
  • 4Ortiz L A,Gambelli F,McBride C,et al.Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects[J].PNAS,2003,100(14):8407-8411.
  • 5Kotton D N,Ma B Y,Cardoso W V,et al.Bone marrow-derived cells as progenitors of lung alveolar epithelium[J].Development,2001,128(24):5181-5188.
  • 6Nilsson S K,Simmons P J.Transplantable stem cells:home to specific niches[J].Curr Opin Hematol,2004,11(2):102-106.
  • 7Ishizawa K,Kubo H,Yamada M,et al.Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema[J].FEBS Lett,2004,556(1-3):249-252.
  • 8Majumdar M K,Thiede M A,Mosca J D,et al.Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells(MSCs)and stromal cells[J].J Cell Physiol,1998,176(1):57-66.
  • 9Villars F,Bordenave L,Bareille R,et al.Effect of human endothelial cells on human bone marrow stromal cell phenotype:role of VEGF[J].J Cell Biochem,2000,79(4):672-685.
  • 10Chen X G,Li Y,Wang L,et al.Ischemic rat brain extracts induce human marrow stromal cell growth factor production[J].Neuropathology,2002,22(4):275-279.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部